Leerink Swann upgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Market Perform to Outperform with a price target of $21.00 (from $16.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE